Brenig Therapeutics, Inc.
Dover, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Brenig Therapeutics, Inc.
Sign up to see every warm intro you have to Brenig Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brenig Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
ID
Iain DukesNamed on SEC filing
NS
Nikolay SavchukNamed on SEC filing
Board
KG
Keno GutierrezBoard director
EM
Edward MathersBoard directorGeneral Partner at NEA Secondary
MC
Michele CuculluBoard director
Investors · 1
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2024
▶$30MraisedJul 2024 · 6 investors · BiotechnologyRule 506(b)
▶$30MraisedJul 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keno GutierrezDirector
- Iain DukesExecutive Officer, Director
- Edward MathersDirector
- Nikolay SavchukExecutive Officer, Director
- Michele CuculluDirector
- Offering amount
- $65M
- Amount sold
- $30M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Brenig Therapeutics, Inc.'s investors?
- Brenig Therapeutics, Inc.'s investors include New Enterprise Associates (NEA).
- How much funding has Brenig Therapeutics, Inc. raised?
- Brenig Therapeutics, Inc. has disclosed $30M raised across 1 round.
- Where is Brenig Therapeutics, Inc. headquartered?
- Brenig Therapeutics, Inc. is headquartered in Dover, US.